Andrew C. Orth

Andrew C. Orth

Chief Commercial OfficeratKrystal Biotech· In proxies 2021–2023

Pay in FY2022-68% from the year before · Krystal Biotech stock +13.3% the same year

Andrew C. Orth was paid $2.9M in FY2022 (Dec), down 68%. Krystal Biotech stock rose 13.3% that year.

Pay$100 in the stock at the end of FY20 → $132
Pay is from the Summary Compensation Table of each Krystal Biotech proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Krystal BiotechPublic company · 5 yr
    • Chief Commercial Officer2021 – Present · 5 yrStock in role +431%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?